Article
Lifetime risk of cancer in carriers of intermediate alleles in the HTT gene.
Scientific reports - 16 Jan 2026
Sundblom Jimmy, Bergdahl Ingvar, Stattin Eva-Lena, Niemelä Valter
Abstract excerpt
Previous studies have found a markedly reduced risk of cancer among Huntington’s disease (HD) patients with CAG ≥ 40, but data on cancer risk at shorter repeat numbers are lacking. The study includes 8149 subjects from Northern Sweden Health and Disease Study. Genotyping yielded a large number of intermediate allele carriers (IA, CAGn 27–35, (n = 497), normal alleles (CAGn 17–26,n = 6584), short alleles...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
